Cryptococcus gattii as an important fungal pathogen of western North America

References

• Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS23(4), 525–530 (2009).
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Rhandhawa SH, Prakash A, Meis JF. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update. Crit. Rev. Microbiol.38(1), 1–16 (2012).
   PubMed Web of Science ®Google Scholar
• Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet336(8720), 923–925 (1990).
   PubMed Web of Science ®Google Scholar
• Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J. Clin. Microbiol.28(7), 1642–1644 (1990).
   PubMed Web of Science ®Google Scholar
• Kidd SE, Chow Y, Mak S et al. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific northwest of the United States. Appl. Environ. Microbiol.73(5), 1433–1443 (2007).
   PubMed Web of Science ®Google Scholar
• Kidd SE, Bach PJ, Hingston AO et al.Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg. Infect. Dis.13(1), 51–57 (2007).
   PubMed Web of Science ®Google Scholar
• Aminnejad M, Diaz M, Arabatzis M et al. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Mycopathologia173(5–6), 337–346 (2011).
   PubMedGoogle Scholar
• Bovers M, Hagen F, Kuramae EE et al. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res.6(4), 599–607 (2006).
   PubMedGoogle Scholar
• McTaggart L, Richardson SE, Seah C, Hoang L, Fothergill A, Zhang SX. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing. J. Clin. Microbiol.49(7), 2522–2527 (2011).
   PubMedGoogle Scholar
• Hagen F, Illnait-Zaragozi MT, Bartlett KH et al.In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrobial Agents Chemother.54(12), 5139–5145 (2010).
   PubMed Web of Science ®Google Scholar
• Kidd SE, Hagen F, Tscharke RL et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl Acad. Sci. USA101(49), 17258–17263 (2004).
   PubMed Web of Science ®Google Scholar
• MacDougall L, Kidd SE, Galanis E et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg. Infect. Dis.13(1), 42–50 (2007).
   PubMed Web of Science ®Google Scholar
• Fraser JA, Giles SS, Wenink EC et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature437(7063), 1360–1364 (2005).
   PubMed Web of Science ®Google Scholar
• Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J. Infect. Dis.199(7), 1081–1086 (2009).
   PubMed Web of Science ®Google Scholar
• Fraser JA, Lim SM, Diezmann S et al. Yeast diversity sampling on the San Juan Islands reveals no evidence for the spread of the Vancouver Island Cryptococcus gattii outbreak to this locale. FEMS Yeast Res.6(4), 620–624 (2006).
   PubMedGoogle Scholar
• Upton A, Fraser JA, Kidd SE et al. First contemporary case of human infection with Cryptococcus gattii in puget sound: evidence for spread of the Vancouver island outbreak. J. Clin. Microbiol.45(9), 3086–3088 (2007).
   PubMed Web of Science ®Google Scholar
• Datta K, Bartlett KH, Baer R et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg. Infect. Dis.15(8), 1185–1191 (2009).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Emergence of Cryptococcus gattii – Pacific Northwest, 2004–2010. MMWR59(28), 865–868 (2010).
   PubMedGoogle Scholar
• Gillece JD, Schupp JM, Balajee SA et al. Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity. PLoS One6(12), E28550 (2011).
   PubMedGoogle Scholar
• Byrnes EJ 3rd, Li W, Lewit Y et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog.6(4), E1000850 (2010).
   PubMed Web of Science ®Google Scholar
• Walraven CJ, Gerstein W, Hardison SE et al. Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One6(12), E28625 (2011).
   PubMedGoogle Scholar
• Harris JR, Lockhart SR, Debess E et al.Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin. Infect. Dis.53(12), 1188–1195 (2011).
   PubMed Web of Science ®Google Scholar
• McCulloh RJ, Phillips R, Perfect JR, Byrnes EJ 3rd, Heitman J, Dufort E. Cryptococcus gattii genotype VGI infection in New England. Pediatr. Infect. Dis. J.30(12), 1111–1114 (2011).
   PubMed Web of Science ®Google Scholar
• Byrnes EJ 3rd, Li W, Lewit Y et al. First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLoS One4(6), E5851 (2009).
   PubMedGoogle Scholar
• Byrnes EJ 3rd, Li W, Ren P et al. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog.7(9), E1002205 (2011).
   PubMedGoogle Scholar
• Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg. Infect. Dis.16(1), 14–20 (2010).
   PubMed Web of Science ®Google Scholar
• Duncan C, Schwantje H, Stephen C, Campbell J, Bartlett K. Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada. J. Wildl. Dis.42(1), 175–178 (2006).
   PubMed Web of Science ®Google Scholar
• Byrnes EJ 3rd, Bildfell RJ, Dearing PL, Valentine BA, Heitman J. Cryptococcus gattii with bimorphic colony types in a dog in western Oregon: additional evidence for expansion of the Vancouver Island outbreak. J. Vet. Diagn. Invest.21(1), 133–136 (2009).
   PubMedGoogle Scholar
• Rotstein DS, West K, Levine G et al.Cryptococcus gattiivgi in a spinner dolphin (Stenella longirostris) from Hawaii. J. Zoo Wildl. Med.41(1), 181–183 (2010).
   PubMedGoogle Scholar
• Miller WG, Padhye AA, van Bonn W, Jensen E, Brandt ME, Ridgway SH. Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii. J. Clin. Microbiol.40(2), 721–724 (2002).
   PubMed Web of Science ®Google Scholar
• Norman SA, Raverty S, Zabek E et al. Maternal–fetal transmission of Cryptococcus gattii in harbor porpoise. Emerg. Infect. Dis.17(2), 304–305 (2011).
   PubMedGoogle Scholar
• Okamoto K, Hatakeyama S, Itoyama S et al.Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg. Infect. Dis.16(7), 1155–1157 (2010).
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg. Infect. Dis.18(1), 172–174 (2012).
   PubMedGoogle Scholar
• Iatta R, Hagen F, Fico C, Lopatriello N, Boekhout T, Montagna MT. Cryptococcus gattii infection in an immunocompetent patient from southern Italy. Mycopathologia doi:10.1007/s11046-011-9493-8 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• MacDougall L, Fyfe M, Romney M, Starr M, Galanis E. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg. Infect. Dis.17(2), 193–199 (2011).
   PubMed Web of Science ®Google Scholar
• Garrett L, Marr KA, West S, Allada G. 74-year-old man from the Pacific Northwest with fever and a lung mass. Chest140(3), 814–817 (2011).
   PubMedGoogle Scholar
• Dewar GJ, Kelly JK. Cryptococcus gattii: an emerging cause of pulmonary nodules. Can. Respir. J.15(3), 153–157 (2008).
   PubMed Web of Science ®Google Scholar
• Iqbal N, DeBess EE, Wohrle R et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J. Clin. Microbiol.48(2), 539–544 (2010).
   PubMed Web of Science ®Google Scholar
• Trilles L, Meyer W, Wanke B, Guarro J, Lazera M. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med. Mycol.50(3), 328–332 (2012).
   PubMed Web of Science ®Google Scholar
• Khan ZU, Randhawa HS, Chehadeh W, Chowdhary A, Kowshik T, Chandy R. Cryptococcus neoformans erotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole. Int. J. Antimicrobial. Agents33(6), 559–563 (2009).
   PubMedGoogle Scholar
• Chong HS, Dagg R, Malik R, Chen S, Carter D. In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype. J. Clin. Microbiol.48(11), 4115–4120 (2010).
   PubMed Web of Science ®Google Scholar
• Bromilow J, Corcoran T. Cryptococcus gattii infection causing fulminant intracranial hypertension. Br. J. Anaesthesia99(4), 528–531 (2007).
   PubMedGoogle Scholar
• Phillips P, Chapman K, Sharp M et al. Dexamethasone in Cryptococcus gattii central nervous system infection. Clin. Infect. Dis.49(4), 591–595 (2009).
   PubMed Web of Science ®Google Scholar
• Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology63(4), 713–714 (2004).
   PubMed Web of Science ®Google Scholar
• Marr KA, Datta K, Pirofski LA, Barnes R. Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency? Clin. Infect. Dis.54(1), 153–154 (2012).
   PubMed Web of Science ®Google Scholar